|Titre :||Global SMART update - Vol. 13. Special segment: Synthetic cannabinoids - Key facts about the largest and most dynamic group of NPS|
|Auteurs :||ONUDC / UNODC|
|Type de document :||Rapport|
|Editeur :||Vienna : UNODC, 2015|
|Collection :||Global SMART Updates, num. Vol.13|
|Format :||12 p. / ill., graph., fig.|
|Discipline :||MAR (Marchés / Markets)|
Thésaurus TOXIBASEPHENOMENE EMERGENT ; DROGUES DE SYNTHESE ; CANNABINOIDES ; TOXICITE ; CONTROLE DES STUPEFIANTS ; SAISIE ; MARCHE DE LA DROGUE
Synthetic cannabinoid receptor agonists, commonly referred to as synthetic cannabinoids, constitute the largest, most diversified and fastest growing group of NPS on the market. Since 2004, several synthetic cannabinoids have been detected in herbal smoking blends which are sold on the Internet and in specialized shops under a variety of brand names such as 'Spice Gold', 'K2', 'Kronic' and 'Yucatan Fire'. These products generally do not contain cannabis but rather synthetic cannabinoids which produce cannabis-like effects.
The special segment of this Global SMART Update provides an overview of the largest group of NPS in the market: synthetic cannabinoids, including their history; current availability on the market; challenges related to legal control; use prevalence and the public health risks associated to their use.
The Update also covers the latest developments in the synthetic cannabinoid market, including the emergence of new generations of synthetic cannabinoids and the legislative responses that different countries are adopting to address this problem. Drug demand-related subjects covered in this issue, include facts that have come to light on the use of synthetic cannabinoids by detainees in New Zealand and the growing concern about fatal and non-fatal intoxications related to the use of synthetic cannabinoids in selected countries.
|Domaine :||Drogues illicites / Illicit drugs|